Safety and Feasibility of Novel Therapy for Duodenal Mucosal Regeneration for Type II Diabetes
Clinical trial NCT05014204 · COMPLETED
Trial details
- NCT number
- NCT05014204
- Sponsor
- Endogenex, Inc.
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-29
- Primary completion
- 2024-05-29
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.